Teladoc Health, Inc. (TDOC)
NYSE • Healthcare
Last close at October 8, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Teladoc Health, Inc. currently loses $6.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 19 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Teladoc Health’s second fiscal quarter of 2026, reported July 29 and based on preliminary results, saw EPS of -$0.21 beat the -$0.24 estimate by about 13% even as revenue fell 4% to about $606.9 million and missed the about $615.4 million consensus by roughly 1%. Revenue was concentrated in the U.S., the largest segment at about $491.5 million, which declined 6%, while Other climbed 25% to about $129.2 million and International rose 17% to about $122.3 million. Gross margin held near 84% and operating margin was about -8%, with operating loss at about $50.1 million and net loss at about $38.9 million, wider than about $32.7 million a year ago. EPS was also down from -$0.19 a year earlier. Operating cash flow came in at about $64.7 million. Next-period consensus calls for EPS of -$0.18 on revenue of $629.2 million.
Next report — what to expect
Teladoc Health, Inc. (TDOC) reports on October 28, 2026, with consensus calling for EPS of -$0.23 on revenue of $590.3 million. For trailing context, revenue fell -4.0% year over year last quarter. TDOC has beaten EPS in 4 of 8 most recent quarters, making outlook versus these expectations a key focus.
About Teladoc Health, Inc.
Teladoc Health, Inc. (NYSE: TDOC) provides digitally delivered healthcare services, from virtual primary and specialized medical care to mental wellness and chronic-condition support, placing it in healthcare technology and care-enablement services. The company generated $2.5 billion in revenue in FY2025.
Today's Snapshot
TDOC is trading 2.1% higher at 5.66, in line with a firmer sector. Teladoc Health launched SoloVitals and SoloScribe, AI tools that expand its Solo virtual-care platform.
Trading Volume
Below 10d avg (3.7M)
1.3M
vs S&P 500 Today
Outperforming Market
+1.57%
Updated: October 9, 2026 at 16:38 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$5.72 - $6.72Sell
- RSI (14)35.89Neutral
- Stochastic %K (14, 3, 3)12.06Buy
- MACD Level (12, 26)-0.26Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.